Biogen Inc Wants to Be the "Fastest-Growing Large-Cap Biotech Company"

Biogen Inc Wants to Be the "Fastest-Growing Large-Cap Biotech Company"

Biogen (NASDAQ: BIIB) started the biotech earnings season off with a bang, generating enough revenue for the company to have confidence to increase its revenue guidance for the year. Earnings weren't nearly as hot, but Biogen has a good excuse: one-time investments in the company's future that lowered the bottom-line results. Beyond the profit-loss statement, Biogen laid out plans for diversifying away from its multiple sclerosis (MS) franchise as it looks to accelerate growth.

Metric

Q2 2017

Continue reading

Source: Fool.com